Chesapeake Research Group, LLC   Report issue

For profit Phase 2 Phase 3
Founded: Pasadena MD United States (2004)

Organization Overview

First Clinical Trial
2011
NCT01462435
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2019

Timeline

NOW
  • Now

Alternative names

Chesapeake Research Group